Maqolada o‘pka surunkali obstruktiv kasalligi bilan xastalangan bemorlarda yurak qon-tomir kasalliklari bilan komorbid kechishi bo‘yicha
ma'lumotlar keltirilgan. O‘SOK bilan kasallangan bemorlar, ularning yoshi va chekish anamnezini hisobga olgan holda, ular doimiy ravishda yuqori
yurak-qon tomir xavfi ostida deb hisoblash mumkin. Bundan tashqari, chekish va yurak-qon tomir kasalliklari ko‘pincha O‘SOK bilan kasallangan
bemorlarda birga keladi va kasallikning diagnostik ko‘rsatkichlari natijalariga ta'sir qilishi mumkin.
O‘SOK bilan kasallangan bemorlarda kardiovaskulyar xavf omillarni baholagan holda yurak qon-tomir xavfi yuqori bo‘lgan bemorlar guruhlarini
aniqlash erta maqsadli profilaktika va aralashuvlarni amalga oshirish imkoniyatini beradi. O‘SOK bilan kasallangan bemorlarda yurak qon-tomir
kasalliklarini komorbid uchrashini erta aniqlash, kasallik klinik kechishini bashoratlash va davolash taktikasini to‘g‘ri tanlash imkoniyatini yaratadi va
buning natijasida kasallanish, nogironlik va o‘lim ko‘rsatkichlarini kamaytirish, bemor hayot sifatini va prognozini yaxshilash muhim ahamiyatga ega.
Maqolada o‘pka surunkali obstruktiv kasalligi bilan xastalangan bemorlarda yurak qon-tomir kasalliklari bilan komorbid kechishi bo‘yicha
ma'lumotlar keltirilgan. O‘SOK bilan kasallangan bemorlar, ularning yoshi va chekish anamnezini hisobga olgan holda, ular doimiy ravishda yuqori
yurak-qon tomir xavfi ostida deb hisoblash mumkin. Bundan tashqari, chekish va yurak-qon tomir kasalliklari ko‘pincha O‘SOK bilan kasallangan
bemorlarda birga keladi va kasallikning diagnostik ko‘rsatkichlari natijalariga ta'sir qilishi mumkin.
O‘SOK bilan kasallangan bemorlarda kardiovaskulyar xavf omillarni baholagan holda yurak qon-tomir xavfi yuqori bo‘lgan bemorlar guruhlarini
aniqlash erta maqsadli profilaktika va aralashuvlarni amalga oshirish imkoniyatini beradi. O‘SOK bilan kasallangan bemorlarda yurak qon-tomir
kasalliklarini komorbid uchrashini erta aniqlash, kasallik klinik kechishini bashoratlash va davolash taktikasini to‘g‘ri tanlash imkoniyatini yaratadi va
buning natijasida kasallanish, nogironlik va o‘lim ko‘rsatkichlarini kamaytirish, bemor hayot sifatini va prognozini yaxshilash muhim ahamiyatga ega.
| № | Author name | position | Name of organisation |
|---|---|---|---|
| 1 | Kamilova U.K. | д.м.н | АО « Республиканский специализированный научно-практический медицинский центр терапии и медицинской реабилитации» |
| 2 | Toshov S.S. | ассистент | Buxoro davlat tibbiyot instituti |
| № | Name of reference |
|---|---|
| 1 | 1. Айсанов З.Р., Чучалин А.Г., Калманова Е.Н. Хроническая обструктивная болезнь легких и сердечно-сосудистая коморбидность. Кардиология. 2019;59(8S):24-36. https://doi.org/10.18087/cardio.2572 2. Клинические рекомендации. Хроническая обструктивная болезнь легких. Межрегиональная общественная организация «Российское Респираторное Общество». 2021. 91 с. 3. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р., Белевский А.С., Лещенко И.В., Овчаренко С.И., Шмелев Е.И. Хроническая обструктивная болезнь легких: федеральные клинические рекомендации по диагностике и лечению. Пульмонология. 2022;32(3):356-392. 4. Report Global strategy for prevention, diagnosis and management of COPD (Global Initiative for Obstructive Lung Disease, GOLD 2021) 5. Ahn YH, Lee KS, Park JH. et al. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations. Respiration. 2015;90(3):199-205. 6. André S, Conde B, Fragoso E, Boléo-Tomé JP, Areias V, Cardoso J; GI DPOC-Grupo de Interesse na Doença Pulmonar Obstrutiva Crónica. COPD and Cardiovascular Disease. Pulmonology. 2019 May-Jun;25(3):168-176. 7. Batura-Gabryel H, Grabicki M. Przewlekła obturacyjna choroba płuc i choroby sercowo-naczyniowe--"kontinuum sercowo-płucne" [Chronic obstructive pulmonary disease and cardiovascular diseases--'cardiopulmonary continuum']. Pneumonol Alergol Pol. 2014;82(6):590-6. 8. Brassington K, Selemidis S, Bozinovski S, Vlahos R. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease. Clin Sci (Lond). 2019 Apr 12;133(7):885-904. 9. Brassington K, Selemidis S, Bozinovski S, Vlahos R. Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics. Clin Sci (Lond). 2022 Mar 31;136(6):405-423. 10. Cazzola M., Calzetta L., Bettoncelli G., et al. Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study. Respiratory Medicine. 2012; 106(2):249-256. 11. Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465817750524. doi: 10.1177/1753465817750524. 12. Patel ARC, Donaldson GC, Mackay AJ, Wedzicha JA, Hurst JR. The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. Chest. 2012 Apr;141(4):851-857. doi: 10.1378/chest.11-0853. Epub 2011 Sep 22. PMID: 21940771. 13. Roversi S, Fabbri LM. Interazioni cuore-polmoni: la broncopneumopatia cronica ostruttiva e la cardiopatia ischemica [Lung and heart interaction: chronic obstructive pulmonary disease and ischemic heart disease]. G Ital Cardiol (Rome). 2018 Mar;19(3):153-160. Italian. doi: 10.1714/2883.29073. PMID: 29873642. 14. Rabe KF, Hurst JR, Suissa S. Cardiovascular disease and COPD: dangerous liaisons? Eur Respir Rev. 2018 Oct 3;27(149):180057 |